Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 24 recruiting now later-stage tilt

ADHD: later-stage trial registry

24 of 77 indexed ADHD trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #175 of 28,707 conditions by registered trial count.

77 US clinical trials · 24 currently recruiting · #175 of 28,707 conditions by registered trial count

ADHD: 77 US clinical trials tracked, 24 recruiting.

ADHD is the subject of 77 registered US clinical trials on ClinicalTrials.gov, 24 of them currently open to new participants. 20 are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most active sponsor is Duke University, running 4 of these trials.

Enrollment posture brief

Registry condition adhd

OPEN 24 | RECR 31% | LATE 20 | EARLY 9 | RANK #175 | SPON 4

Nearest open-share peer: Eosinophilic Esophagitis (31% recruiting · 45 trials)

Acute Kidney Injury44%Tobacco Use42.9%Fibromyalgia33.8%ADHD (this)31%Age-related Macular Degenera26.7%
Open-enrollment share among volume-matched conditions near ADHD

ADHD lists 24 open slots (31% of 77 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for ADHD on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. ADHD is recruiting below its size-band peers.

    24 of 77 indexed trials (31.2%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of ADHD trials is spread across many organizations.

    Duke University accounts for 4 of 77 trials (5.2%). 52 distinct sponsors appear on at least one study for this condition label.

  3. Typical ADHD enrolment sits around 72 participants.

    Median target enrolment is 72 among the 76 trials that report a genuine target (sentinel values excluded). 41 of those (53.9%) plan for fewer than 100 participants.

  4. ADHD research is mostly interventional.

    67 interventional and 10 observational studies make up this index (87% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 16Phase 23Phase 310Phase 410

Open and recent trials

77 total, page 2 of 2

COMPLETED 106 participants

Behavioral Effects of Obstructive Sleep Apnea in Children

University of Michigan

NCT00060723

COMPLETED Phase 3 90 participants

Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD

Novartis

NCT00141063

COMPLETED NA 72 participants

A Peer-Delivered High School Preparatory Intervention for Students With ADHD

Seattle Children's Hospital

NCT04571320

COMPLETED NA 69 participants

Effects of Performing Arts on Attention-deficit/Hyperactivity Disorder (ADHD)

Virginia Polytechnic Institute and State University

NCT07318935

COMPLETED NA 65 participants

A Novel fNIRS Neurofeedback Intervention for Enhancement of Working Memory in Attention Deficit Hyperactivity Disorder (ADHD)

Stanford University

NCT04002167

COMPLETED NA 59 participants

Brain Plasticity Underlying Acquisition of New Organizational Skills in Children

NYU Langone Health

NCT04108273

COMPLETED NA 59 participants

Tai Chi Training for Children With ADHD

Hugo W. Moser Research Institute at Kennedy Krieger

NCT02234557

COMPLETED Phase 4 48 participants

Basic and Clinical Research on Attention Deficit Hyperactivity Disorder (ADHD)

University of Illinois at Chicago

NCT00663442

COMPLETED 48 participants

Initial Validation of the Vanderbilt ADHD Measure for Adolescent Patients in the ICISS Project

Boston Children's Hospital

NCT01964209

COMPLETED NA 42 participants

Brain Plasticity Underlying Acquisition of New Organizational Skills in Children-R61 Phase

NYU Langone Health

NCT03148782

COMPLETED Phase 4 38 participants

Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance?

Florida International University

NCT01127607

COMPLETED NA 36 participants

Effects of Noise Cancelling Headphones on Neurocognitive and Academic Outcomes in ADHD

Duke University

NCT03216512

COMPLETED Phase 4 36 participants

Study of Medication Patch to Treat Children Ages 6-12 With ADHD

Massachusetts General Hospital

NCT00586157

COMPLETED NA 35 participants

Pediatric Aquatic Occupational Therapy for Children With Sensory Processing Challenges

Kristen Pataki

NCT06484946

COMPLETED NA 32 participants

El Faro: Addressing Mental Health Inequities Among Latinx Children With ADHD in Durham

Duke University

NCT05928182

COMPLETED Phase 1 31 participants

Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD)

Vernalis (R&D)

NCT02253745

COMPLETED NA 29 participants

Study of the Effect of Calorie Supplementation on Growth in Young Children on ADHD Medication

University of Nebraska

NCT00561340

COMPLETED NA 28 participants

Effects of Exercise Intensity on ADHD Symptoms

Kent State University

NCT06753253

COMPLETED Phase 1 27 participants

The Reinforcing Mechanisms of Smoking in Adult ADHD

University of California, Irvine

NCT00573859

COMPLETED NA 26 participants

Effects of Cognitive Training on Academic Task Performance in Attention Deficit Hyperactivity Disorder (ADHD)

University of California, Davis

NCT01124721

COMPLETED Phase 1 24 participants

Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD

Yale University

NCT03103750

COMPLETED NA 20 participants

ACTIVATE: A Computerized Training Program for Children With ADHD

New York University

NCT02562469

COMPLETED Early Phase 1 20 participants

Validating a New Non-invasive Approach to Testing Lidocaine Effectiveness

PhenoSolve

NCT03680885

COMPLETED NA 14 participants

Treating Sleep in Teens With ADHD

Children's Hospital Medical Center, Cincinnati

NCT04270812

COMPLETED NA 7 participants

Improving Behavioral Health Care for Children With ADHD

NYU Langone Health

NCT02972086

COMPLETED Phase 1 6 participants

TD-9855 Mass Balance Study

Theravance Biopharma

NCT01924143

COMPLETED Phase 3

Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHD

Cephalon

NCT00228540

← Previous Page 2 of 2

Phase Distribution

PhaseTrial count
Phase 1 6
Phase 2 3
Phase 3 10
Phase 4 10

Named interventions

Most-linked intervention names on ADHD records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
12 trials
Methylphenidate Drug
4 trials
Organizational Skills Training Behavioral
3 trials
PRC-063 oral capsules Drug
2 trials
TD-9855 Drug
2 trials
ADHD Therapy Device
2 trials
Placebo oral capsules Drug
2 trials
Behavioral Parent Training (BPT) Behavioral
2 trials

US sites by state

Facility locations filed on ADHD trials. A trial with sites in several states counts in each.

Florida 17 trials
California 17 trials
New York 15 trials
Massachusetts 13 trials
Ohio 11 trials
Pennsylvania 9 trials
North Carolina 9 trials
Nevada 8 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this ADHD page

77 registered trials, 24 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This ADHD condition card totals 77 registered trials; most-linked intervention Placebo; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.